Biotaitan Molmed Co., Ltd. focused on developing rapid real-time quantitative PCR (rRT-PCR) platform for point-of-care testing (POCT). The platform is designed for molecular precision testing applications in healthcare facilities, ambulances, clinics, pharmacies and homes. At the latest trade show, Biotaitan launched AcesoBox, a portable POCT rRT-PCR device. The device uses a patented rapid thermal cycle system that integrates multi-channel optical detection, allowing users to process samples through simple extraction and obtain up to 15 target results within 5-10 minutes, demonstrating excellent market competitiveness.

Thailand is facing dual challenges of an aging population and insufficient healthcare resources in rural areas. S.S.S. Automotive Industry Co., Ltd., a global leader in ambulances, plans to collaborate with Taiwan’s technology industry to further enhance the functionality and efficiency of its smart ambulances, aiming to improve the quality of healthcare services for the elderly population in Thailand’s remote regions.

With the rapid growth of smart healthcare and digital health in the ASEAN region, EP Plus Group Sdn Bhd, a leading healthcare company in ASEAN with a network of over 4,000 partner clinics, recently visited Taiwan to discuss collaboration opportunities. The focus includes expanding the medical device market, particularly in gastrointestinal and diabetes treatment products, while further exploring the potential of digital health and the medical aesthetics industry.

Pharmaniaga, Malaysia's largest publicly listed pharmaceutical company, operates across the entire pharmaceutical value chain, from R&D and the production of generic and over-the-counter drugs to logistics, distribution, sales, and marketing. Now, Pharmaniaga is officially extending a hand of collaboration to Taiwanese pharmaceutical companies, actively seeking partners to jointly explore opportunities in the ASEAN biopharmaceutical market.

Indonesia's healthcare market holds immense potential, with the market size projected to reach $2.2 billion by 2024. As a leading provider of medical diagnostic equipment in the country, Sugih plays a pivotal role in Indonesia's healthcare industry and is actively driving digital transformation. The company aims to leverage Taiwan's expertise in AI diagnostics, data management, and health platform technologies to accelerate the modernization of Indonesia's healthcare system.

The Philippine government is actively promoting the upgrade of its pharmaceutical industry, announcing the establishment of a dedicated economic zone for the sector. This initiative includes tax incentives and expedited drug testing and registration pathways, lowering barriers for international companies entering the Philippine market. As one of the top two pharmaceutical distributors in the Philippines, Ambica represents over 3,000 products from 50 countries worldwide. This time, their visit to Taiwan focuses on seeking partnerships with Taiwanese pharmaceutical companies, aiming to jointly drive the $4 billion pharmaceutical market collaboration boom.

Under the Dubai Industrial Strategy 2030, pharmaceuticals and medical devices have been identified as one of the six key industries for development, highlighting the UAE's ambition to become a global pharmaceutical hub. Planet Pharmacies LLC, a subsidiary of the Julphar Group and one of the largest pharmaceutical suppliers in the Middle East and Africa, will leverage the Taiwan Healthcare+ Expo to seek partnerships in biotechnology, regenerative medicine, and precision diagnostics.

When mentioning Thailand, many people think of the world-renowned Thai massage. However, its physical therapy and rehabilitation technologies are also experiencing rapid growth. Thailand's leading brand in the field of physical therapy, **STP**, will participate in the **2024 Taiwan Healthcare+ Expo**, seeking Taiwanese partners to create new opportunities in Thailand's physical therapy market.

With the rapid growth of healthcare demand in Indonesia, medical OEM/ODM is becoming a key driver of the country's healthcare industry development. Against this backdrop, PT. Trisa Likuid Farma from Indonesia is participating in Taiwan's Healthcare Technology Expo to establish collaborations with Taiwan's advanced medical technology companies and explore innovative solutions for medical devices and home healthcare products.

Saudi Arabia holds a central position in the Middle Eastern healthcare market, with smart healthcare and digital health becoming pivotal pillars in its medical transformation. The market is growing at an annual rate of 10%. This year, Tamer Health Care, a century-old healthcare group from Saudi Arabia, is participating in the 2024 Taiwan Healthcare Expo, focusing on Taiwan's cutting-edge technologies in smart hospital management systems, telemedicine platforms, and AI medical solutions.

The Philippine government’s active promotion of universal healthcare has significantly improved the country’s medical infrastructure and service quality, directly driving demand in the medical device market. **SERVE DIAGNOSTICA INC**, a renowned IVD distributor in the Philippines, will participate in the Taiwan Healthcare+ Expo this December at the Taipei Nangang Exhibition Center, seeking partnerships and expanding its international business opportunities.

According to market forecasts, the global CDMO market is projected to reach $143.7 billion by 2024 and surpass $247.9 billion by 2029, with a compound annual growth rate (CAGR) of 11.52%. **Nippon Shokubai Co., Ltd.**, a leading global player in the chemical industry, will participate in the 2024 Taiwan Healthcare+ Expo to seek partnerships in Taiwan and explore potential opportunities in the biotech and pharmaceutical sectors.

The application of medical robots is becoming increasingly widespread, playing a crucial role in daily healthcare tasks. Take the seemingly simple task of urinary care as an example, which has traditionally been performed by healthcare professionals. However, with the onset of an aging society, the loads for medical cares but shortage of healthcare personnel has become an increasingly serious problem. In response to these challenges, research teams have been working continuously through discussions and clinical trials to improve the design of medical robots._x000D_
_x000D_
Our solution not only helps reduce the burden on healthcare workers but also improves the quality of medical services. In the future, we expect more types of medical robots to emerge, making significant contributions to human health and well-being._x000D_

Wine-Font Inc. is leading provider of cutting-edge medical devices, will showcase its latest range of diagnostic solutions at the upcoming Healthcare Expo Taiwan. The company is committed to empowering healthcare professionals with accurate and reliable tools for improved patient care. _x000D_
_x000D_
Key products on display include:_x000D_
* Roche cobas b 101 system: A comprehensive biochemistry analyzer for HbA1c, lipid profile, and CRP testing._x000D_
* Roche cobas h232 cardiac reader: A high-precision cardiac marker analyzer for rapid and accurate results._x000D_
* Urisys® 1100 urine analyzer: A reliable urine analyzer with connectivity to cobas POC IT solution._x000D_
* Radiometer ABL9 blood gas analyzer: A comprehensive blood gas analyzer for critical care settings. _x000D_
* Roche CoaguChek XS system: A portable coagulation monitoring system for patient self-testing.